Clinical trial assessing VSL#3 for the treatment of anterior resection syndrome

ANZ Journal of Surgery

Volumn 82, Issue 6, 2012, Pages 420-427

  Stephens, Jacqueline H ^a,b   Hewett, Peter J ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Colorectal neoplasms; Colorectal surgery; Ileostomy; Probiotics; Quality of life

Indexed keywords

PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; ILEOSTOMY; IRRITABLE COLON; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECTUM; RECTUM TUMOR; SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COLONIC DISEASES, FUNCTIONAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ILEOSTOMY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROBIOTICS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECTAL NEOPLASMS; RECTUM; SYNDROME; TREATMENT OUTCOME;

EID: 84861898213     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2012.06082.x     Document Type: Article

References (36)

1. Camilleri-Brennan J, Steele RJ. Prospective analysis of quality of life after reversal of a defunctioning loop ileostomy. Colorectal Dis. 2002; 4: 167-71.
2. Rao GN, Drew PJ, Lee PW, Monson JR, Duthie GS. Anterior resection syndrome is secondary to sympathetic denervation. Int. J. Colorectal Dis. 1996; 11: 250-8.
3. Ortiz H, Armendariz P. Anterior resection: do the patients perceive any clinical benefit? Int. J. Colorectal Dis. 1996; 11: 191-5.
4. Williamson ME, Lewis WG, Finan PJ, Miller AS, Holdsworth PJ, Johnston D. Recovery of physiologic and clinical function after low anterior resection of the rectum for carcinoma: myth or reality? Dis. Colon Rectum 1995; 38: 411-8.
5. Lewis WG, Martin IG, Williamson ME etal. Why do some patients experience poor functional results after anterior resection of the rectum for carcinoma? Dis. Colon Rectum 1995; 38: 259-63.
6. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.
7. Chermesh I, Eliakim R. Probiotics and the gastrointestinal tract: where are we in 2005? World J. Gastroenterol. 2006; 12: 853-7.
8. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhoea in children: a meta-analysis. Dig. Dis. Sci. 2002; 47: 2625-34.
9. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhoea in children. J. Pediatr. 1999; 135: 564-8.
10. Bazzocchi G, Gionchetti P, Almerigi PF, Amadini C, Campieri M. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. Dig. Liver Dis. 2002; 34: S48-53.
11. Kühbacher T, Ott SJ, Helwig U etal. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006; 55: 833-41.
12. Katz JA, Fiocchi C. Probiotic therapy of IBD. Inflamm. Bowel Dis. Monit. 2001; 2: 106-11.
13. Kim HJ, Camilleri M, McKinzie S etal. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2003; 17: 895-904.
14. Gionchetti P, Lammers KM, Rizzello F, Campieri M. VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol. Clin. North Am. 2005; 34: 499-513.
15. Gionchetti P, Rizzello F, Helwig U etal. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-9.
16. Gionchetti P, Rizzello F, Venturi A etal. Oral bacteriotherapy as maintenance treatment in patient with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-9.
17. Mimura T, Rizzello F, Helwig U etal. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-14.
18. Campieri M, Rizzello F, Venturi A etal. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study versus mesalamine. Gastroenterology 2000; 118: A4179.
19. Eypasch E, Williams JI, Wood-Dauphinee S etal. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br. J. Surg. 1995; 82: 216-22.
20. Sailer M, Bussen D, Debus ES, Fuchs KH, Thiede A. Quality of life in patients with benign anorectal disorders. Br. J. Surg. 1998; 85: 1716-9.
21. Greenhouse SW, Geisser S. On methods in the analysis of profile data. Psychometrika 1959; 24: 95-112.
22. Mansfield SD, Jensen C, Phair AS, Kelly OT, Kelly SB. Complications of loop ileostomy closure: a retrospective cohort analysis of 123 patients. World J. Surg. 2008; 32: 2101-6.
23. Roediger WE. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 1980; 2: 712-5.
24. Roediger WE. The starved colon - diminished mucosal nutrition, diminished absorption, and colitis. Dis. Colon Rectum 1990; 33: 858-62.
25. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 1989; 320: 23-8.
26. Butzner JD, Parmar R, Bell CJ, Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 1996; 38: 568-73.
27. Finnie IA, Dwarakanath AD, Taylor BA, Rhodes JM. Colonic mucin synthesis is increased by sodium butyrate. Gut 1995; 36: 93-9.
28. Säemann MD, Böhmig GA, Osterreicher CH etal. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 2000; 14: 2380-2.
29. Ogawa H, Rafiee P, Fisher PJ, Johnson NA, Otterson MF, Binion DG. Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem. Biophys. Res. Commun. 2003; 309: 512-9.
30. Longatti TS, Acedo SC, de Oliveira CC etal. Inflammatory alterations in excluded colon in rats: a comparison with chemically induced colitis. Scand. J. Gastroenterol. 2010; 45: 315-24.
31. Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, Schmitz F. Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr. Cancer 2009; 61: 103-13.
32. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient compliance with paper and electronic diaries. Control. Clin. Trials 2003; 24: 182-99.
33. Anhoj J, Moldrup C. Feasibility of collecting diary data from asthma patients through mobile phones and SMS (short message service): response rate analysis and focus group evaluation from a pilot study. J. Med. Internet Res. 2004; 6: e42.
34. Gorbach SL. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 2000; 95 (Suppl): S2-4.
35. Kakodkar R, Gupta S, Nundy S. Low anterior resection with total mesorectal excision for rectal cancer: functional assessment and factors affecting outcome. Colorectal Dis. 2006; 8: 650-6.
36. Desnoo L, Faithfull S. A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery. Eur. J. Cancer Care (Engl) 2006; 15: 244-51.